Search results
Goldman Sachs CEO downplays firm’s report on Harris’ economic plan
FOX Business· 6 days agoThe CEO of Goldman Sachs weighed in on Vice President Harris' comments during Tuesday night's...
What can go wrong for risk after a 50bps Fed cut? Goldman answers
StreetInsider· 4 hours agoAccording to Goldman Sachs, while a 50bps rate cut by the Fed on Wednesday may seem positive for risk assets in the short term, there are potential challenges ...
Meet the ex-Googler joining Goldman Sachs to build tech and optimize its investment banking and...
Business Insider· 12 hours agoThis story is available exclusively to Business Insider subscribers. Become an Insider and start...
Goldman Sachs initiates coverage on US hotel stocks By Investing.com
Investing.com· 16 hours agoGoldman Sachs initiates coverage on US hotel stocks
Goldman Sachs bullish on Aviva with new Buy rating, GBP5.72 stock PT By Investing.com
Investing.com· 13 hours agoOn Wednesday, Goldman Sachs initiated coverage on Aviva PLC (LSE:LON:AV), listing the stock with a Buy rating and setting a price target of GBP5.72. The ...
Goldman Sachs strategists share their final pre-FOMC thoughts By Investing.com
Investing.com· 16 hours agoGoldman Sachs strategists anticipate the Federal Reserve will opt for a 50 basis point (bp) rate cut...
IHG upgraded to Buy at Goldman Sachs; Whitbread downgraded to Neutral By Investing.com
Investing.com· 22 hours agoGoldman Sachs in a note dated Wednesday has revised its ratings in the European hotel sector,...
Biotech stocks are an unappreciated way to profit from lower rates, Goldman says
CNBC· 13 hours agoAs investors await the Federal Reserve rate decision Wednesday afternoon, Goldman Sachs highlighted...
Brokerage firm rates Phoenix Group with sell, sets GBP5.43 stock target By Investing.com
Investing.com· 13 hours agoOn Wednesday, Goldman Sachs initiated coverage on Phoenix Group Holdings (PHNX:LN) (OTC: PHXXF), issuing a Sell rating with a price target of GBP5.43. The ...
This Small-Cap Stock Has a Promising GLP-1 Drug That Could Rival Novo Nordisk's and Eli Lilly's...
The Motley Fool· 16 hours agoGoldman Sachs projects that the anti-obesity market will be worth as much as $100 billion by the end...
